2026 Q1 -tulosraportti
88 päivää sitten
‧1 t 2 min
18,00 DKK/osake
Viimeisin osinko
5,64%Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 7 | - | - | ||
| 31 | - | - | ||
| 10 | - | - | ||
| 20 | - | - | ||
| 108 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 82 759 | 82 759 | 0 | 82 759 |
| Anonyymi | 59 198 | 59 198 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 82 759 | 82 759 | 0 | 82 759 |
| Anonyymi | 59 198 | 59 198 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 12.5. | 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.2. | ||
Vuosittainen yhtiökokous 2025 4.12.2025 | ||
2025 Q4 -tulosraportti 4.11.2025 | ||
2025 Q3 -tulosraportti 19.8.2025 | ||
2025 Q2 -tulosraportti 6.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·1 päivä sittenHopefully the news from last Friday can give the stock a bit of a lift. Coloplast secures special contract for wound dressing in USA 1/5 15:00 Coloplast has secured a special contract for its wound dressing Biatain Silicone Fit from the American purchasing giant Vizient. This is an "Innovative Technology Contract", which Vizient awards to products deemed to have the potential to, among other things, improve the patient experience and treatment course, Coloplast states in a press release. - Innovation in wound care must solve real clinical challenges, says Fertram Sigurjonsson, head of Coloplast's division Wound & Tissue Repair. - Our 3DFit technology is designed to do exactly that - to help prevent pressure ulcers and provide effective wound care. Another advantage is that the dressing can be removed to inspect the skin and then reapplied instead of being discarded. This can reduce product waste and improve efficiency, the director continues. Vizient is responsible for purchasing products for, among others, hospitals, healthcare providers, and other healthcare facilities in the USA. The company's portfolio has a value of more than 140 billion dollars in annual purchasing volume. .\˙ MarketWire
·1.5.Hi - is it true that a dividend is paid on this stock here in May? and what do you think speaks for/against investing in Coloplast currently? :) :)
·1 päivä sittenWhat speaks for and against investing in Coloplast? The question is probably very much about whether Coloplast is a growth stock or a value stock. For many years, Coloplast has been a growth stock. In recent years, there has been less growth. Will growth return? The stock is on its way to being valued as a value stock. It's probably not quite there yet. If growth returns, there will be significant potential when the pricing changes to reflect expectations of growth. So, if one is to make money on Coloplast, I would wait until it is fully priced as a value stock - and then it should be even cheaper. Or wait for growth to be announced for several quarters - and then there will be significant potential.
·30.4.TA - I am out since 430 broken, but am shocked that we see 400 ...a weekly close below 400 points directly towards the old 340-350 level from summer 2013 where I remember it went into total BUY and largely didn't look back ...before 550 / 666 / and 1200+ right now we are almost seeing the same steps in reverse order unfortunately .....I am looking for 340/50 or a break above 450 on a weekly basis .
30.4.30.4.Next year if rasmussen is in the lead next summer we all have at least - 50% for sure.
·30.4.New CEO, will be fantastic. All worse news is out. From here it will be good I think.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
88 päivää sitten
‧1 t 2 min
18,00 DKK/osake
Viimeisin osinko
5,64%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 päivä sittenHopefully the news from last Friday can give the stock a bit of a lift. Coloplast secures special contract for wound dressing in USA 1/5 15:00 Coloplast has secured a special contract for its wound dressing Biatain Silicone Fit from the American purchasing giant Vizient. This is an "Innovative Technology Contract", which Vizient awards to products deemed to have the potential to, among other things, improve the patient experience and treatment course, Coloplast states in a press release. - Innovation in wound care must solve real clinical challenges, says Fertram Sigurjonsson, head of Coloplast's division Wound & Tissue Repair. - Our 3DFit technology is designed to do exactly that - to help prevent pressure ulcers and provide effective wound care. Another advantage is that the dressing can be removed to inspect the skin and then reapplied instead of being discarded. This can reduce product waste and improve efficiency, the director continues. Vizient is responsible for purchasing products for, among others, hospitals, healthcare providers, and other healthcare facilities in the USA. The company's portfolio has a value of more than 140 billion dollars in annual purchasing volume. .\˙ MarketWire
- ·1.5.Hi - is it true that a dividend is paid on this stock here in May? and what do you think speaks for/against investing in Coloplast currently? :) :)·1 päivä sittenWhat speaks for and against investing in Coloplast? The question is probably very much about whether Coloplast is a growth stock or a value stock. For many years, Coloplast has been a growth stock. In recent years, there has been less growth. Will growth return? The stock is on its way to being valued as a value stock. It's probably not quite there yet. If growth returns, there will be significant potential when the pricing changes to reflect expectations of growth. So, if one is to make money on Coloplast, I would wait until it is fully priced as a value stock - and then it should be even cheaper. Or wait for growth to be announced for several quarters - and then there will be significant potential.
- ·30.4.TA - I am out since 430 broken, but am shocked that we see 400 ...a weekly close below 400 points directly towards the old 340-350 level from summer 2013 where I remember it went into total BUY and largely didn't look back ...before 550 / 666 / and 1200+ right now we are almost seeing the same steps in reverse order unfortunately .....I am looking for 340/50 or a break above 450 on a weekly basis .
- 30.4.30.4.Next year if rasmussen is in the lead next summer we all have at least - 50% for sure.·30.4.New CEO, will be fantastic. All worse news is out. From here it will be good I think.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 7 | - | - | ||
| 31 | - | - | ||
| 10 | - | - | ||
| 20 | - | - | ||
| 108 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 82 759 | 82 759 | 0 | 82 759 |
| Anonyymi | 59 198 | 59 198 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 82 759 | 82 759 | 0 | 82 759 |
| Anonyymi | 59 198 | 59 198 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 12.5. | 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.2. | ||
Vuosittainen yhtiökokous 2025 4.12.2025 | ||
2025 Q4 -tulosraportti 4.11.2025 | ||
2025 Q3 -tulosraportti 19.8.2025 | ||
2025 Q2 -tulosraportti 6.5.2025 |
2026 Q1 -tulosraportti
88 päivää sitten
‧1 t 2 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 12.5. | 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.2. | ||
Vuosittainen yhtiökokous 2025 4.12.2025 | ||
2025 Q4 -tulosraportti 4.11.2025 | ||
2025 Q3 -tulosraportti 19.8.2025 | ||
2025 Q2 -tulosraportti 6.5.2025 |
18,00 DKK/osake
Viimeisin osinko
5,64%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 päivä sittenHopefully the news from last Friday can give the stock a bit of a lift. Coloplast secures special contract for wound dressing in USA 1/5 15:00 Coloplast has secured a special contract for its wound dressing Biatain Silicone Fit from the American purchasing giant Vizient. This is an "Innovative Technology Contract", which Vizient awards to products deemed to have the potential to, among other things, improve the patient experience and treatment course, Coloplast states in a press release. - Innovation in wound care must solve real clinical challenges, says Fertram Sigurjonsson, head of Coloplast's division Wound & Tissue Repair. - Our 3DFit technology is designed to do exactly that - to help prevent pressure ulcers and provide effective wound care. Another advantage is that the dressing can be removed to inspect the skin and then reapplied instead of being discarded. This can reduce product waste and improve efficiency, the director continues. Vizient is responsible for purchasing products for, among others, hospitals, healthcare providers, and other healthcare facilities in the USA. The company's portfolio has a value of more than 140 billion dollars in annual purchasing volume. .\˙ MarketWire
- ·1.5.Hi - is it true that a dividend is paid on this stock here in May? and what do you think speaks for/against investing in Coloplast currently? :) :)·1 päivä sittenWhat speaks for and against investing in Coloplast? The question is probably very much about whether Coloplast is a growth stock or a value stock. For many years, Coloplast has been a growth stock. In recent years, there has been less growth. Will growth return? The stock is on its way to being valued as a value stock. It's probably not quite there yet. If growth returns, there will be significant potential when the pricing changes to reflect expectations of growth. So, if one is to make money on Coloplast, I would wait until it is fully priced as a value stock - and then it should be even cheaper. Or wait for growth to be announced for several quarters - and then there will be significant potential.
- ·30.4.TA - I am out since 430 broken, but am shocked that we see 400 ...a weekly close below 400 points directly towards the old 340-350 level from summer 2013 where I remember it went into total BUY and largely didn't look back ...before 550 / 666 / and 1200+ right now we are almost seeing the same steps in reverse order unfortunately .....I am looking for 340/50 or a break above 450 on a weekly basis .
- 30.4.30.4.Next year if rasmussen is in the lead next summer we all have at least - 50% for sure.·30.4.New CEO, will be fantastic. All worse news is out. From here it will be good I think.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 7 | - | - | ||
| 31 | - | - | ||
| 10 | - | - | ||
| 20 | - | - | ||
| 108 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 82 759 | 82 759 | 0 | 82 759 |
| Anonyymi | 59 198 | 59 198 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 82 759 | 82 759 | 0 | 82 759 |
| Anonyymi | 59 198 | 59 198 | 0 | 0 |